SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Jan-24 5:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Jan-24 | Grant | 5,000 | -- | -- | 11% 46.2K to 51.2K | |
07-Jun-23 9:32 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 490 | $37.87 | $18,553.90 | (1%) 36.81K to 36.32K | |
07-Jun-23 9:32 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 471 | $38.99 | $18,364.80 | (1%) 37.28K to 36.81K | |
05-Aug-22 4:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Aug-22 | Market Sale | 308 | $55.70 | $17,155.60 | (< 1%) 37.39K to 37.08K | (10%) |
07-Jul-22 7:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jul-22 | Market Sale | 924 | $57.19 | $52,841.70 | (2%) 38.31K to 37.39K | (7%) |
08-Jun-22 7:45 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 9,900 | -- | -- | 35% 28.2K to 38.1K | |
08-Jun-22 7:45 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Market Sale | 362 | $61.37 | $22,217.40 | (1%) 28.56K to 28.2K | < 1% |
25-May-22 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 23-May-22 | Option Exercise | 2,000 | $52.37 | $104,740.00 | 8% 26.56K to 28.56K | |
05-Aug-21 4:29 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Aug-21 | Grant | 5,000 | -- | -- | 23% 21.35K to 26.35K |